Inventor · disambiguated record
Weiru Wang
Also filed as: WANG WEIRU
16 granted patents·10 pending applications·325 citations·filing 2004–2024
93Inventor score
Top patents by PatentIndex Score
26 records- 0197US7572806B2PPAR active compoundsPLEXXIKON INC·Filed 2007·Granted Aug 11, 2009·59 cites·5 claims
- 0297US7348338B2PPAR active compoundsPLEXXIKON INC·Filed 2004·Granted Mar 25, 2008·79 cites·9 claims
- 0396US8367828B2PPAR active compoundsPLEXXIKON INC·Filed 2010·Granted Feb 5, 2013·54 cites·7 claims
- 0495US11566003B2Isoquinolines as inhibitors of HPK1GENENTECH INC·Filed 2020·Granted Jan 31, 2023·4 cites·31 claims
- 0595US8053463B2PPAR active compoundsPLEXXIKON INC·Filed 2008·Granted Nov 8, 2011·45 cites·8 claims
- 0695US7202266B2PPAR active compoundsPLEXXIKON INC·Filed 2004·Granted Apr 10, 2007·65 cites·54 claims
- 0790US10407424B2Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2018·Granted Sep 10, 2019·5 cites·72 claims
- 0888US9453079B2Methods and compositions for neural disease immunotherapyGENENTECH INC·Filed 2014·Granted Sep 27, 2016·9 cites·35 claims
- 0981US11034692B1Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Jun 15, 2021·1 cites·20 claims
- 1080US11612606B28-aminoisoquinoline compounds and uses thereofGENENTECH INC·Filed 2019·Granted Mar 28, 2023·2 cites·29 claims
- 1175US2024368170A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 1271US9193766B2Peptide inhibitors of BACE1GENENTECH INC·Filed 2012·Granted Nov 24, 2015·1 cites·16 claims
- 1364US8772457B2BACE1 antibodiesATWAL JASVINDER·Filed 2011·Granted Jul 8, 2014·1 cites·28 claims
- 1462US2022073520A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 1555US9879094B2Nucleic acid molecules encoding for BACE1 antibodiesGENENTECH INC·Filed 2016·Granted Jan 30, 2018·0 cites·27 claims
- 1654US2018282282A1Isoquinolines as inhibitors of hpk1GENENTECH INC·Filed 2018·Application pending·0 cites
- 1753US12473301B2Isoquinoline compounds for the treatment of cancerGENENTECH INC·Filed 2021·Granted Nov 18, 2025·0 cites·18 claims
- 1853US9382257B2Substituted pyrrolo[2,3-b]pyrazines as serine/threonine kinase inhibitorsGENENTECH INC·Filed 2015·Granted Jul 5, 2016·0 cites·7 claims
- 1952US2022112308A1Kras specific antibodies and uses thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 2050US9624269B2Peptide inhibitors of BACE1GENENTECH INC·Filed 2015·Granted Apr 18, 2017·0 cites·12 claims
- 2149US2008221127A1Ppar active compoundsPLEXXIKON INC·Filed 2008·Application pending·0 cites
- 2247US2012015966A1Ppar active compoundsLIN JACK·Filed 2011·Application pending·0 cites
- 2345US2008249137A1PPAR active compoundsLIN JACK·Filed 2006·Application pending·0 cites
- 2445US2007072904A1PPAR active compoundsLIN JACK·Filed 2006·Application pending·0 cites
- 2543US2006135540A1PPAR active compoundsLIN JACK·Filed 2005·Application pending·0 cites
- 2642US2006160135A1SF-1 and LRH-1 modulator developmentWANG WEIRU·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Weiru Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →